Impact of a pharmacist-driven tardive dyskinesia screening service

• Κύριοι συγγραφείς: Niyati Butala, PharmD, BCPP (Συγγραφέας), Andrew Williams, PharmD, BCPP, BCGP (Συγγραφέας), Jamie Kneebusch, PharmD, BCPS, BCPP (Συγγραφέας), Melissa Mitchell, PharmD, BCPS, BCPP, BCGP (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: American Association of Psychiatric Pharmacists, 2021-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Introduction: Tardive dyskinesia (TD) is defined as involuntary movements that can develop with prolonged antipsychotic use. Regular monitoring using the Abnormal Involuntary Movement Scale (AIMS) is recommended to be conducted every 3 to 6 months for early recognition, although the AIMS is underuse...